Alcoholic hepatitis symptoms are clinical signs of acute liver inflammation caused by excessive alcohol consumption, including jaundice, abdominal tenderness, fever, and elevated liver enzymes. These symptoms develop rapidly over days to weeks and indicate significant liver damage requiring immediate medical evaluation.
Alcoholic hepatitis results from direct toxic injury to liver cells by ethanol and its metabolite acetaldehyde. Chronic alcohol exposure triggers immune activation, leading to inflammation, fat accumulation, and cell death. The condition typically affects people with a history of heavy drinking-defined as more than 60 grams of alcohol daily for men and 40 grams for women-over several years.
Early recognition is critical. A 2021 study published in *Hepatology* found that patients presenting with fever and elevated bilirubin had a 30-day mortality rate of 24%, compared to 7% in those without fever. This underscores the urgency of identifying symptoms promptly.
The liver processes alcohol through enzymatic pathways involving alcohol dehydrogenase (ADH) and cytochrome P450 2E1 (CYP2E1). These enzymes produce reactive oxygen species and acetaldehyde, which damage hepatocytes and disrupt mitochondrial function. Over time, this leads to steatosis (fatty liver), ballooning degeneration, and Mallory-Denk bodies-pathognomonic protein aggregates seen under microscopy.
Inflammatory cytokines such as TNF-alpha and IL-6 are released, recruiting neutrophils and macrophages to the liver. This immune response amplifies tissue injury. The resulting hepatic dysfunction manifests clinically as jaundice, ascites, and coagulopathy due to impaired synthetic function.
A 2023 review in *The Lancet Gastroenterology & Hepatology* noted that 50% of patients with severe alcoholic hepatitis have abnormal mental status within the first week, indicating hepatic encephalopathy-a sign of advanced disease.
Key symptoms include:
Patients may also exhibit palmar erythema, spider angiomas, and gynecomastia-signs of chronic liver disease. However, these are less specific and may appear in other conditions.
Alcoholic hepatitis severity is assessed using the Maddrey Discriminant Function (MDF):
| Score | Interpretation | Prognosis |
|---|---|---|
| < 32 | Mild disease | 8-week survival ~90% |
| ≥32 | Severe disease | 8-week survival ~50% |
The MDF uses serum bilirubin (mg/dL) and prothrombin time (seconds) to calculate risk. A score ≥32 indicates high mortality and warrants corticosteroid therapy or consideration for liver transplant in select cases.
Non-alcoholic causes of similar symptoms-such as viral hepatitis, autoimmune hepatitis, or drug-induced liver injury-must be ruled out. For example, autoimmune hepatitis typically presents with elevated IgG and positive antinuclear antibodies, whereas alcoholic hepatitis shows negative autoantibodies and a history of alcohol abuse.
Many patients delay seeking care because they attribute symptoms to "just a hangover." A 2022 survey in *JAMA Internal Medicine* found that 68% of individuals with alcoholic hepatitis reported experiencing fatigue and nausea for over two weeks before consulting a provider.
Another common error is mistaking alcoholic hepatitis for fatty liver disease. While both stem from alcohol misuse, fatty liver is asymptomatic in most cases and lacks inflammatory markers. Alcoholic hepatitis involves necroinflammation, confirmed by biopsy or imaging.
Symptom severity does not always correlate with histological damage. Some patients with mild clinical features show severe fibrosis on imaging. This disconnect highlights the need for objective testing-not just symptom reporting.
A 48-year-old man presented with jaundice, abdominal pain, and a temperature of 38.2°C. He reported drinking 12 beers daily for five years. Lab tests showed AST 180 U/L, ALT 85 U/L, bilirubin 4.2 mg/dL, and INR 1.6. His MDF score was 48, indicating severe disease.
He was hospitalized, started on prednisolone 40 mg/day, and underwent a liver ultrasound showing hepatomegaly and increased echogenicity. After seven days, his bilirubin dropped to 2.1 mg/dL, and he reported improved energy. Alcohol cessation was enforced during admission.
This case illustrates that early intervention improves outcomes. Delayed treatment increases risk of complications like variceal bleeding, infection, and renal failure.
If you or someone you know experiences persistent jaundice, unexplained fever, or worsening abdominal pain after heavy drinking, seek medical attention immediately. Blood tests for liver function, imaging, and possibly a liver biopsy confirm diagnosis.
Complete abstinence from alcohol is essential. Continued drinking worsens prognosis-studies show 1-year mortality exceeds 50% in patients who relapse after diagnosis.
Recovery depends on stopping alcohol, nutritional support, and treating complications. In severe cases, corticosteroids or pentoxifylline may be used. Liver transplantation remains an option for eligible patients with refractory disease.
Recognizing alcoholic hepatitis symptoms early saves lives. The presence of jaundice, fever, and abnormal liver tests should trigger urgent evaluation-not dismissal as temporary discomfort.